Clinical trials
Ischemic Attack, Transient trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunnybrook Health Sciences Centre | 7 |
| University of Alberta | 7 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 5 |
| AstraZeneca | 3 |
| Bayer | 2 |
| Ottawa Heart Institute Research Corporation | 2 |
| Baycrest | 1 |
| Bristol-Myers Squibb | 1 |
| C. T. Lamont Primary Care Research Centre | 1 |
| Dr. Richard H. Swartz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Attack, Transient | 45 |
| Stroke | 28 |
| Ischemic Stroke | 8 |
| Atrial Fibrillation | 4 |
| Cognitive Dysfunction | 4 |
| Hypertension | 4 |
| Sleep Apnea, Obstructive | 4 |
| Alzheimer Disease | 3 |
| Cardiovascular Diseases | 3 |
| Carotid Stenosis | 3 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.